Atsushi Watanabe
Daisen, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Pharmacokinetics of asciminib in a patient with chronic myeloid leukemia undergoing maintenance hemodialysis.
Journal: Cancer chemotherapy and pharmacology
Published: May 04, 2026
Clinical Practice of Treatment Switch in Transplant-eligible Patients with Multiple Myeloma: An Exploratory Retrospective Analysis.
Journal: Internal medicine (Tokyo, Japan)
Published: September 18, 2025
Overexposure to venetoclax is associated with prolonged-duration of neutropenia during venetoclax and azacitidine therapy in Japanese patients with acute myeloid leukemia.
Journal: Cancer chemotherapy and pharmacology
Published: January 22, 2024
Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy.
Journal: International journal of clinical oncology
Published: September 27, 2023
Thrombocytopenia Caused by a Tea Beverage of Taxus yunnanensis (Chinese Yew).
Journal: Internal medicine (Tokyo, Japan)
Published: July 12, 2019
Successful management of splenomegaly with ruxolitinib prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia transformed from post-polycythemia vera myelofibrosis.
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 07, 2017
Enhancing the throughput and multiplexing capabilities of next generation sequencing for efficient implementation of pooled shRNA and CRISPR screens.
Journal: Scientific reports
Published: November 24, 2016
Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Journal: Oncotarget
Published: September 10, 2015
MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.
Journal: Blood
Published: January 04, 2014
Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: January 16, 2013
Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
Journal: Oncogene
Published: December 07, 2012
Bortezomib reduces the tumorigenicity of multiple myeloma via downregulation of upregulated targets in clonogenic side population cells.
Journal: PloS one
Published: October 11, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026